Apertus Pharmaceuticals, LLC Files Notice of Registration with the DEA for Controlled Substances

Summary

Apertus Pharmaceuticals, LLC has submitted a notice of registration with the U.S. Drug Enforcement Administration (DEA) for the manufacture, distribution, and dispensing of controlled substances, as required by law.